Membrane Rupture: Term PROM and PPROM

Pre-labor rupture of membranes (PROM) is the rupture of fetal membranes before regular uterine contractions begin. When it occurs before 37 0/7 weeks, it is called preterm PROM (PPROM); PPROM is responsible for approximately one-third of preterm births and is the most common single identifiable factor associated with preterm birth. Term PROM occurs in approximately 8% of pregnancies—as high as 28% in a prospective population survey of more than 10,000 singleton, vertex, live births in France (UpToDate 2026). Although the two charts share the same event, their management logics are diametrically opposed: in term PROM the aim is to shorten latency, in PPROM it is to extend it (up to 34 weeks).

Diagnosis

Diagnosis is based on the characteristic history (vaginal fluid leakage) and sterile speculum examination where fluid is seen draining from the cervix. If the diagnosis is uncertain, nitrazine and fern tests are performed on the fluid pooled in the posterior fornix. Clinical findings and diagnostic approach are the same in all weeks of pregnancy (UpToDate 2026).

Commercial immunoassay tests—primarily testing that detects placental alpha microglobulin-1 (PAMG-1) in cervicovaginal secretion—have replaced traditional speculum evaluation in some centers. However, the FDA has issued a warning about the risks of using the test alone (Thumm 2020). In a retrospective analysis involving 302 patients between 17 and 41 weeks of gestation in a tertiary triage unit (68.9% intact, 31.1% ruptured), sensitivity was found to be 95.7%, specificity 92.3%, positive predictive value 84.9% and negative predictive value 98.0% when the test was used alone; 16 false positive and 4 false negative results were detected. When the same test was combined with clinical evaluation and used in a protocol, sensitivity increased to 98.2%, specificity increased to 99.5%, and positive and negative predictive values ​​increased to 100% (Thumm 2020). The practical implication is clear: biomarker testing is not a replacement for a speculum examination, but rather alongside it.

Ultrasonography alone does not make the diagnosis, but it shows the amniotic fluid volume. Components of the initial evaluation include: confirmation of membrane rupture, determination of fetal presentation, assessment of fetal well-being by nonstress testing, and maternal assessment—contractions, signs of infection (fever, fetal tachycardia, maternal leukocytosis, purulent discharge), and oligohydramnios (single deepest pocket <2 cm or amniotic fluid index ≤5 cm; associated with increased risk of infection). Initially, a complete blood count is taken; Leukocytosis is a nonspecific finding and can also occur with non-infectious inflammation, but an increase in the white blood cell count above 20,000/mm³ or a significant shift to the left is a warning sign of chorioamnionitis or another focus of infection (UpToDate 2026).

Term PROM (≥37 0/7 Weeks)

After Term PROM, approximately 70% of patients enter spontaneous labor within the first 12 hours, nearly 90% within 24 hours, and 99% within 48 hours (UpToDate 2026). The fundamental question in management is whether to wait for spontaneous labor or to induce it; The risk of maternal infection is higher in patients undergoing expectant management.

The backbone of the evidence is the TERMPROM study and the meta-analyses that include it. In a 2021 meta-analysis of nine randomized trials involving nearly 3800 patients with singleton pregnancies who developed PROM at ≥36 weeks, induction with oxytocin at ≤12 hours after membrane rupture compared with induction after >12 hours (waiting time 24–96 hours in most studies) yielded the following results (Bellussi 2021, meta-analysis):

Subgroup analysis evaluating induction at ≤6 hours after membrane rupture yielded similar results (Bellussi 2021). The quality of evidence of the studies was low–moderate (antibiotic use was not clearly defined, some outcomes were not reported, digital cervical examination was used in older studies); however, the significant reduction in neonatal sepsis is particularly important because this outcome can be fatal. In the secondary analysis of TERMPROM, the composite neonatal infection or intensive care admission rate was lower in the induction group during the first 20 hours (adjusted RR 0.71 at 15–19 hours; 0.53–0.93), and cesarean section rates remained similar in the two groups, unchanged over time (Melamed 2023, TERMPROM secondary analysis).

Prompt delivery is therefore recommended in term PROM: induction is performed as soon as possible if labor and vaginal delivery are not contraindicated. ACOG also recommends delivery at PROM at ≥37 0/7 weeks, but notes that short-term expectant management may be recommended (ACOG Practice Bulletin 217, 2020).

Induction Method: Oxytocin, Not Balloon Catheter

If there is no obstacle to labor and vaginal birth, induction with oxytocin is recommended without cervical ripening before induction [Grade 2B] (UpToDate 2026). Oxytocin is more easily titrated than prostaglandins and may be less expensive depending on the prostaglandin preparation chosen; Meta-analyses of randomized trials have not shown a significant superiority of using prostaglandins at baseline over oxytocin in patients with PROM, including those with an unfavorable cervix (UpToDate 2026). There are clinicians who prefer ripening with misoprostol or PGE 2 in patients with unfavorable cervix; Studies conducted in this subgroup are few and small.

Pending Management and Antibiotics

Patients with otherwise uncomplicated pregnancies who do not wish to seek immediate intervention may choose waiting management; In these patients, fetal testing should be reassuring, there should be no obstruction to labor and vaginal birth, and there should be no clinical chorioamnionitis or any other complication whose risk would increase with postponement of birth. There are no strong data for an upper limit of duration: pending management in TERMPROM was limited to 96 hours, and the risk of chorioamnionitis appeared to increase markedly after 24 hours (TERMPROM, Hannah 1996) — making 24 hours a reasonable limit. On the other hand, waiting longer allows more patients to enter spontaneous labor: in the same study, 50% of patients undergoing expectant management were in active labor at about 17 hours, 95% at about 75 hours (TERMPROM, Hannah 1996).

Hospital monitoring is recommended even if expectant management is preferred: When the TERMPROM study group compared expectant management at home and hospital, clinical chorioamnionitis was more common in patients sent home (10.1% vs. 6.4%), and the risk of neonatal infection was found to be higher in those monitored at home (OR 1.97; 1.00–3.90 — Hannah 2000). If home monitoring is still desired, reasonable criteria are: cephalic presentation, no suspicion of intrauterine infection, negative GBS culture, reassuring FHR monitoring, absence of oligohydramnios, patient's ability to follow instructions, help at home and reliable transportation, journey to the hospital not longer than 20–30 minutes, pulse and temperature measurement every six hours (notify physician if pulse >100/min or temperature ≥38 °C) and daily fetal movement count. (UpToDate 2026).

Group B streptococcus (GBS): Induction is recommended in patients with GBS colonization (ACOG PB 217, 2020). In secondary analysis of TERMPROM, induction with oxytocin in GBS-positive patients was associated with a lower rate of neonatal infection compared with expectant management (2.5% vs >8%—TERMPROM secondary analysis, 1997). If antepartum culture is positive—whether induction or expectant management is chosen—maternal intravenous antibiotic prophylaxis should be initiated as soon as possible after PROM to reduce the risk of early-onset neonatal GBS disease. If culture is negative, GBS prophylaxis is not indicated; Intrapartum fever is managed according to usual protocols. If culture has not been performed or the result is unknown, the decision is based on standard risk factor assessment.

PPROM (23 0/7 – 36 6/7 Weeks)

PPROM management is one of the most controversial topics in perinatal medicine; Points of discussion are accurate diagnosis in problematic cases, intervention versus expectant management, use of tocolytics, selection and duration of prophylactic antibiotics, timing of antenatal corticosteroid, maternal/fetal infection testing methods, and timing of birth (UpToDate 2026). Factors evaluated at admission: gestational age, presence of maternal/fetal infection, presence of labor, fetal presentation, fetal status, expected lung maturity according to gestational age, cervical status (visually assessed) and availability of appropriate neonatal care.

There is agreement for close monitoring and expectant management until at least 34 0/7 weeks for PPROM before 34 0/7 weeks if there are no complications [Grade 2C]. Two components of expectant management in stable patients less than 34 0/7 weeks have strong recommendation: antenatal corticosteroid [Grade 1A] and prophylactic antibiotic [Grade 1A] (UpToDate 2026).

Antenatal Corticosteroid and Magnesium

A course of corticosteroids is administered to PPROM cases presenting between 23 0/7 and 33 6/7 weeks. In meta-analyses of randomized trials, antenatal corticosteroid treatment provided a significant reduction in neonatal death, respiratory distress syndrome, intraventricular hemorrhage, necrotizing enterocolitis, and duration of neonatal respiratory support, and did not increase maternal or neonatal infection; The average risk reduction for these events is in the range of 30–60% (UpToDate 2026). A course may be considered in patients presenting between 34 0/7 – 36 6/7 weeks who are scheduled for expectant management, have not previously received steroids, and are scheduled to deliver after 24 hours but less than 7 days—but this is more controversial. Up to 34 weeks, a single rescue course may be administered to patients who have received steroids more than 14 days previously and are at high risk of delivery within 7 days; Multiple cycles should be avoided (provides no additional benefit, may be harmful; UpToDate 2026).

Magnesium sulfate is administered before birth according to standard clinical protocols for fetal neuroprotection (e.g., pregnancies less than 32 weeks, at risk of imminent delivery, and for neonatal resuscitation if necessary) (UpToDate 2026).

Latency Antibiotic

The aim of antibiotic treatment is to reduce the frequency of maternal and fetal infection, thus delaying the onset of preterm labor and indicated preterm delivery. In a Cochrane review of 22 placebo-controlled randomized trials and more than 6800 pregnant women, antibiotic use significantly reduced: chorioamnionitis (RR 0.66; 95% CI 0.46–0.96), birth within 48 hours (RR 0.71; 0.58–0.87) and seven days (RR 0.79; 0.71–0.89) after randomisation, neonatal infection. (RR 0.67; 0.52–0.85), surfactant use (RR 0.83; 0.72–0.96), neonatal oxygen therapy (RR 0.88; 0.81–0.96) and pre-discharge abnormal cerebral ultrasound (RR 0.81; 0.68–0.98) — Kenyon 2013, Cochrane.

The rationale for the regimen is that ampicillin and amoxicillin specifically target GBS, many aerobic gram-negative bacilli, and some anaerobes; Azithromycin covers Ureaplasma, which can be an important cause of chorioamnionitis, and Chlamydia trachomatis, which is an important cause of neonatal conjunctivitis and pneumonia. Azithromycin is preferred over the multi-day course of erythromycin due to ease of administration, gastrointestinal tolerance, cost, and similar or better efficacy; In a 2022 meta-analysis of five observational studies involving nearly 1300 pregnant women with PPROM, azithromycin was associated with a lower rate of clinical chorioamnionitis compared with erythromycin (14.5% vs 24.4%; OR 0.53; 0.39–0.71; UpToDate 2026). In patients with GBS colonization, the intravenous portion of the regimen (ampicillin 2 g IV/6 hours, 48 ​​hours) provides adequate prophylaxis; After the seven-day course is completed, the antibiotic is discontinued and, if the GBS culture is positive, GBS-specific prophylaxis (e.g., penicillin) is restarted when the patient goes into labor.

This is where agencies differ: ACOG recommends antibiotic prophylaxis to prolong latency at <34 0/7 weeks PPROM, but not for ≥34 0/7 weeks undergoing expectant management (ACOG PB 217, 2020). RCOG and NICE recommend antibiotic prophylaxis for 10 days after PPROM or until labor is established and do not use a threshold of 34 0/7 weeks (RCOG GTG 73, 2019).

Tocolysis, Monitoring and Special Situations

The main indication for tocolysis in PPROM is to delay birth for 48 hours to allow a course of antenatal corticosteroids to be given; it may also be used to reduce the risk of birth during transfer to a center with a higher level of neonatal care. As a rule, it should not be continued for more than 48 hours ; it should not be given to patients in advanced labor (>3–4 cm dilation) or with findings suggestive of subclinical or overt chorioamnionitis. Other possible contraindications include nonreassuring fetal test results, placental abruption and a substantial risk of cord prolapse. In a 2014 systematic review of pregnancies before 34 weeks, tocolysis reduced birth within 48 hours (RR 0.59; upper limit 1.00), but increased chorioamnionitis (RR 1.79; 1.02–3.14) and did not significantly improve perinatal morbidity or mortality (UpToDate 2026).

Hospital monitoring of patients with PPROM is recommended; Data for ambulatory administration are of low precision and equivalence or benefit has not been clearly demonstrated. Concerns include delay in diagnosis of maternal infection, cord compression and/or prolapse, fetal death, and rapid delivery. In a retrospective review of 187 outpatient PPROM patients (24–35 weeks), severe complications were observed in 12 (fetal death, detachment, cord prolapse, birth outside the delivery room, neonatal death); Before 26 weeks, PPROM, noncephalic presentation, and oligohydramnios significantly increase the risk and—especially if more than one—is an indication for hospitalization (UpToDate 2026). Thromboprophylaxis is applied to hospitalized patients due to the possibility of deep vein thrombosis and pulmonary embolism due to sedentary stay.

Fetal monitoring usually uses one method (movement count, NST, biophysical profile); In many centers, daily NST is performed and if it does not provide confidence, biophysical profile is applied. However, none of these tests have good sensitivity in predicting fetal infection, even when performed daily—sensitivities of daily NST and biophysical profile have been reported as 39% and 25%, respectively (UpToDate 2026). PPROM does not change the way the biophysical profile is calculated or interpreted; Since a low score may be due to infection or oligohydramnios and lack of fetal breathing due to PPROM, its predictive value for infection is low. Fetal growth assessment is not performed more often than two to three weeks. Umbilical artery Doppler monitoring is not useful in PPROM unless there is accompanying fetal growth restriction.

During maternal monitoring, at least routine clinical parameters (fever, uterine tenderness, contraction frequency, maternal and fetal heart rate) are monitored; Periodic monitoring of white blood cell counts or other markers of inflammation has not proven helpful. Amniocentesis is not routinely performed to screen for intraamniotic infection in asymptomatic patients; If the clinical diagnosis of chorioamnionitis is unclear and additional information is required for a pending management decision, Gram stain, culture may be performed for leukocyte esterase, glucose, and interleukin-6 (if available). Up to 50% of patients do not have enough amniotic fluid to sample; In this case, the diagnosis of chorioamnionitis is based on clinical examination and indirect tests such as abnormal peripheral white blood cell count (UpToDate 2026).

Expectant management after PPROM in patients with a cerclage in place is a separate topic, and the decision whether to remove the cerclage is individualized. In patients using vaginal progesterone for a short cervix, the medication is discontinued once PPROM is diagnosed; continuing vaginal administration may increase the risk of ascending infection. A meta-analysis of five randomized trials involving 545 participants showed that additional progesterone supplementation does not prolong latency (UpToDate 2026). Meconium-stained fluid is evaluated for signs of chorioamnionitis; in the absence of such findings, meconium alone is not an indication for intervention.

Birth Timing and 34–37 Weeks Discussion

There are no high-quality data to clearly demonstrate at what point the further gestational age gain provided by expectant management ceases to offset the risks of prolonged PPROM. The optimal timing varies from institution to institution and depends on the balance between morbidity due to prematurity (respiratory distress syndrome, intraventricular hemorrhage, necrotizing enterocolitis) and morbidity due to PPROM complications (chorioamnionitis, detachment, cord accidents).

The 34–37 week range is where the evidence is most contested. A Cochrane meta-analysis of randomized trials in PPROM before 37 weeks (Bond 2017; 12 studies, 3617 patients) concluded that expectant management until 37 weeks is preferable to planned preterm birth in the absence of maternal or fetal deterioration. Planned preterm birth increased respiratory distress syndrome (RR 1.26; 1.05–1.53), need for mechanical ventilation (RR 1.27; 1.02–1.58), neonatal intensive care admission (RR 1.16; 1.08–1.24), and neonatal death (RR 2.55; 1.17–5.56) compared with expectant management; however, it did not reduce neonatal sepsis (RR 0.93; 0.66–1.30) or overall perinatal mortality (RR 1.76; 0.89–3.50). For the mother, planned preterm birth reduced chorioamnionitis (RR 0.50; 0.26–0.95) and shortened hospital stay, but increased caesarean section (RR 1.26; 1.11–1.44) and endometritis (RR 1.61; 1.00–2.59) (Bond 2017, Cochrane).

In a 2018 meta-analysis of individual participant data (3 studies, 2563 participants) combining only studies of late PPROM (34 0/7 – 36 6/7 weeks), immediate delivery versus expectant management were similar in composite adverse neonatal outcome (9.6% vs 8.3%; RR 1.20, 0.94–1.55). For the mother, immediate delivery reduced antepartum bleeding (1.7% vs. 3.0%; RR 0.57, 0.34–0.95) and chorioamnionitis (1.3% vs. 6.4%; RR 0.21, 0.13–0.35) and modestly increased cesarean section (22% vs. 18%; RR 1.26, 1.08–1.47) (2018 meta-analysis with individual participant data; UpToDate 2026).

A single study (PPROMT) accounts for approximately half of these meta-analyses, and the generalizability of the results is questionable: the studies were conducted for periods of up to nine years, during a period of marked change in obstetric and neonatal care (especially the widespread use of CPAP rather than intubation/mechanical ventilation); Corticosteroid, tocolytic and prophylactic antibiotic applications were left to local protocols; The PROM–induction interval in preterm birth arms varied significantly between studies, and some patients were monitored as outpatients (PPROMT, Lancet 2016; UpToDate 2026). Additionally, in a secondary analysis of PPROMEXIL studies, the rate of early-onset neonatal sepsis was increased with expectant management in GBS-positive pregnancies (15.2% vs 1.8%); In PPROMT, sepsis rates in GBS-positive patients were similar (3.8% vs. 3.6% — PPROMT, Lancet 2016) — the difference in antibiotic administration between the two studies (92% vs. 40%) may explain this divergence. In the 10-year follow-up of PPROMEXIL, it was reported that pending management at 34–36 weeks did not improve childhood outcomes compared to induction (UpToDate 2026).

Mode of delivery and cervical ripening: If there are no contraindications to labor and vaginal birth, most patients deliver vaginally—via spontaneous labor or induction—while cesarean delivery is reserved for standard obstetric indications. Once delivery is decided, a digital cervical examination assesses whether the cervix is favorable. If the cervix is favorable (Bishop ≥6), oxytocin is administered per standard protocol; if unfavorable, a prostaglandin (misoprostol or PGE₂) may be used—although the benefit of cervical ripening agents in pregnancies with ruptured membranes is unproven. An intracervical balloon catheter is not used in this clinical setting either, as data suggest that introducing a foreign body may increase the risk of infection (Mackeen 2021).

Periviable PPROM, Oligohydramnios and Consequences

PPROM at the threshold of viability is a distinct counseling area. Patients experiencing previable PROM are advised to be hospitalized once they reach the gestational age at which neonatal resuscitation would be offered; the exact timing of admission is determined by each institution's viability threshold and the patient's preferences. In PPROM cases presenting at 22 weeks, if delivery is expected within the next seven days and the family — following detailed counseling with maternal-fetal medicine and neonatology specialists — desires active neonatal intervention, antenatal corticosteroid administration is also reasonable (UpToDate 2026).

Early, severe, and prolonged oligohydramnios may be associated with pulmonary hypoplasia, facial deformity, and orthopedic abnormalities; These complications are most common when membrane rupture occurs before 23 weeks (UpToDate 2026). Oligohydramnios is also associated with an increased risk of umbilical cord compression and shorter latency, but this finding alone is of low predictive value for adverse fetal/neonatal outcome.

Neonatal morbidity and mortality are mainly due to preterm birth; Residual oligohydramnios also plays a role. The type and frequency of prematurity-related morbidity depends on the gestational age at birth and the presence of chorioamnionitis; Fetal exposure to intrauterine inflammation has been associated with an increased risk of neurodevelopmental disorders. Approximately one-third of patients with maternal PPROM develop infections that can be serious, such as chorioamnionitis or endometritis; The frequency of infection is higher if PPROM occurs in earlier weeks of pregnancy, and endometritis is more common after cesarean than vaginal birth (UpToDate 2026).

Subsequent pregnancies: A history of PPROM is a strong risk factor for recurrence. In some cases, PPROM may be associated with cervical insufficiency; In subsequent pregnancies, sonographic cervical length measurement and placement of a cerclage if cervical length is ≤25 mm before 24 weeks may reduce the risk of recurrent preterm birth. For short cervix, daily vaginal progesterone is an alternative approach. Screening for asymptomatic infections and treatment of positives or empirical antibiotic therapy has not been proven to prevent PPROM (UpToDate 2026).

Clinical Summary

• Diagnosis: history + fluid flow from os on sterile speculum; nitrazine and ferning in posterior fornix fluid if unclear. PPV when using PAMG-1 immunoassay alone was 84.9% (16 false positives in 302 patients); PPV 100% when used within protocol with clinical evaluation — FDA warns against use alone (Thumm 2020).
• 🔴 Digital cervicovaginal examination is not performed before labor begins (risk of chorioamnionitis). Presentation is determined by ultrasound/Leopold.
• Term PROM: 70% of patients enter spontaneous labor within 12 hours, 90% within 24 hours, and 99% within 48 hours. Induction at ≤12 hours reduces neonatal sepsis (6.1% vs 11.8%), chorioamnionitis, endometritis, and intensive care unit admission; does not increase caesarean section (Bellussi 2021).
• In Term PROM, induction is done with oxytocin, without a maturation agent. 🔴 No balloon catheter used — RR of intraamniotic infection compared to oxytocin alone 3.20 (1.17–8.70; Mackeen 2021).
• Prophylactic antibiotics are not recommended in Term PROM (no significant differences in chorioamnionitis, endometritis, and latency; Saccone 2015). If GBS is positive, IV prophylaxis is started immediately, regardless of induction or waiting (ACOG PB 217, 2020).
• PPROM <34 0/7 weeks: expectant management + antenatal corticosteroid [Grade 1A] + latency antibiotic [Grade 1A]. Corticosteroid 23 0/7 – 33 6/7 weeks; 34 0/7 – 36 6/7 is more controversial. Magnesium sulfate according to standard protocol for neuroprotection (e.g. <32 weeks).
• Latency antibiotic: azithromycin 1 g oral + ampicillin 2 g IV/6 hours × 48 hours, followed by amoxicillin 875 mg orally 2×1 (or 500 mg 3×1) for five days. 🔴 Amoxicillin-clavulanate is avoided — risk of NEC RR 4.72 (1.57–14.23; Kenyon 2013, Cochrane).
• Institutional separation: ACOG recommends antibiotic for <34 0/7 weeks, not for expectant management at ≥34 0/7 weeks (ACOG PB 217, 2020); RCOG and NICE recommend 10 days or until labor is established and do not use a threshold of 34 weeks (RCOG GTG 73, 2019).
• Tocolysis only for the purpose of a 48-hour delay (or transfer) course of corticosteroids; No longer than 48 hours, no advanced labor or evidence of chorioamnionitis. It increases chorioamnionitis in pregnancies less than 34 weeks (RR 1.79; UpToDate 2026).
• Follow-up: in hospital. Daily NST/BPP is poor at predicting fetal infection (sensitivity 39% and 25%). Umbilical artery Doppler is useless if there is no growth restriction. Amniocentesis is not routine if the clinical diagnosis is unclear.
• 34–37 weeks: In the 2017 Cochrane review, expectant management until 37 weeks was favored over planned early delivery (with early delivery: neonatal death RR 2.55, RDS RR 1.26, cesarean delivery RR 1.26; Bond 2017); in a 2018 individual participant data meta-analysis, the composite neonatal outcome was similar, whereas immediate delivery significantly reduced chorioamnionitis (RR 0.21). ACOG considers both options acceptable in this gestational range (ACOG PB 217, 2020).
• Periviable PPROM: Severe oligohydramnios at rupture before 23 weeks is associated with pulmonary hypoplasia, facial deformity, and orthopedic abnormalities; The decision for admission and steroids is individualized by institutional viability threshold, family preference, and MFM–neonatology consultation.

← All scientific guides